New Key Statistics Module, Z-Score and F-Score
OTCPK:VMTHF Key Ratios
| Market Cap $ M | 318.89 |
| Enterprise Value $ M | 320.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.84 |
| Price/Sales | 4.86 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 64.00 |
| EPS (TTM) $ | -0.18 |
| Beneish M-Score | -2.41 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -16.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.27 |
| EV-to-EBITDA | -5.59 |
| PEG | -- |
| Shares Outstanding M | 441.01 |
| Net Margin (%) | -120.30 |
| Operating Margin % | -96.19 |
| Pre-tax Margin (%) | -124.28 |
| Quick Ratio | 1.97 |
| Current Ratio | 2.22 |
| ROA % (ttm) | -12.61 |
| ROE % (ttm) | -18.74 |
| ROIC % (ttm) | -13.67 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.18 |
VMTHF Number of Guru Trades
VMTHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:VMTHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:VMTHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Venus Medtech (Hangzhou) Inc Insider Transactions
No Available Data
News about OTCPK:VMTHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers